New insights into the drug treatment of ventricular arrhythmias.
D000889:Anti-Arrhythmia Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000378:metabolism; D001949:Bretylium Compounds / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D008012:Lidocaine / Q000031:analogs & derivatives / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D016677:Tocainide
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D016677:Tocainide; D008012:Lidocaine; D011433:Propranolol; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide